Clinical Trial Update: AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer [NA]

View source ↗

Summary

This clinical trial update notes completion of a study evaluating AZD2171 (cediranib) in combination chemotherapy for women with locally advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AZD2171 (cediranib)
• Combination chemotherapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer | NA | Status: COMPLETED